Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Gantenerumab, Solanezumab, Matching Placebo (Gantenerumab) and Matching Placebo (Solanezumab) for patients with Alzheimers Disease, Dementia or Alzheimers Disease, Familial

Birmingham Alabama 35294

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Tuscaloosa Alabama 35404

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Arizona

Phoenix Arizona

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating florbetapir F 18 and 18F-AV-1451 for the treatment of Chronic Traumatic Encephalopathy

Sun City Arizona

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

View More ▼

Tucson Arizona

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Tucson Arizona

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Tucson Arizona

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Arkansas

Little Rock Arkansas

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

California

Pharmacology Research Institute, Encino
Encino California 91316

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6124 or Placebo in Subjects with Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6124 or Placebo in Subjects with Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

You may qualify for a medical research study evaluating an investigational drug for memory loss. Participants must be at least 50 years of age and have noticed changes in your memory or your judgment.

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6125 or Placebo in Subjects with Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

Northern California Research
Sacramento California 95821

Patients with Mild-Moderate Alzheimer's Disease

Schuster Medical Research Institute
Sherman Oaks California 91403

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).

View More ▼

Bellflower California 90706

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Bellflower California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Costa Mesa California

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Costa Mesa California 92627

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Costa Mesa California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Culver City California

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Downey California

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Downey California 90241

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Encino California

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Fremont California

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Glendale California

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Glendale California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Irvine California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

La Jolla California 92037

A clinical trial to evaluate treatments using Gantenerumab, Solanezumab, Matching Placebo (Gantenerumab) and Matching Placebo (Solanezumab) for patients with Alzheimers Disease, Dementia or Alzheimers Disease, Familial

La Jolla California 92037

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Laguna Hills California

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Long Beach California

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Los Alamitos California

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Los Angeles California

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Oceanside California

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Orange California

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Orange California 92868

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Redding California

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Redlands California 92373

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

San Diego California

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

San Diego California

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

San Francisco California

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Yorba Linda California 92886

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Colorado

Denver Colorado

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Connecticut

New Haven Connecticut 06510

A clinical trial to evaluate treatments using Gantenerumab, Solanezumab, Matching Placebo (Gantenerumab) and Matching Placebo (Solanezumab) for patients with Alzheimers Disease, Dementia or Alzheimers Disease, Familial

Norwalk Connecticut 06851

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia